Explores how dexmedetomidine protects the brain from injury by activating BDNF-TrkB signaling, suggesting therapeutic potential.
Dexmedetomidine exerts significant neuroprotective effects by activating the BDNF/TrkB signaling pathway, thereby alleviating ischemic brain injury.
No takes yet. Share an insight, caveat, or question.
Simayi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: